- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ViroGates A/S (VIROG)
Copenhagen
Currency in DKK
Disclaimer
5.75
+0.10(+1.77%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.75
5.75
52 wk Range
4.98
21.90
VIROG Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ViroGates A/S stock price live, this page displays CSE VIROG stock exchange data. View the VIROG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ViroGates A/S real time stock price chart below.
What Is the ViroGates A/S Stock Price Today?
The ViroGates A/S stock price today is 5.75.
What Is the Stock Symbol for ViroGates A/S?
The stock symbol for ViroGates A/S is "VIROG."
What Stock Exchange Does ViroGates A/S Trade On?
ViroGates A/S is listed and trades on the Copenhagen stock exchange.
Is ViroGates A/S a Good Stock to Buy?
Determining whether ViroGates A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VIROG quote. (ISIN: DK0061030574)
What Is the ViroGates A/S Stock Price Today?
The ViroGates A/S stock price today is 5.75.
What Is the Stock Symbol for ViroGates A/S?
The stock symbol for ViroGates A/S is "VIROG."
What Stock Exchange Does ViroGates A/S Trade On?
ViroGates A/S is listed and trades on the Copenhagen stock exchange.
Is ViroGates A/S a Good Stock to Buy?
Determining whether ViroGates A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VIROG quote. (ISIN: DK0061030574)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.755.75
52 wk Range
4.9821.90
UnlockVIROG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
ViroGates Company Profile
ViroGates A/S, an in vitro diagnostics company, develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital emergency services to support the clinical decision on hospitalization or discharge of acute patients and to identify high-risk sepsis patients at an early stage, as well as used for the prognosis of lifestyle-related diseases, such as cardiovascular disease, type 2 diabetes, and cancer; and for the assessment of longevity and biological age in a non-hospital setting. The company’ products icludes suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the soluble urokinase plasminogen activator receptor (suPAR) level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic ELISA that provides fully quantitative results; suPARnostic Quick Triage kit, which is used in the point of care situation for early warning and patient triaging that will allow clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression and outcome; and suPARnostic POC+, a point-of-care finger prick test that detects the level of suPAR in the blood. The company was founded in 2000 and is headquartered in Birkerød, Denmark.
Compare VIROG to Peers and Sector
Metrics to compare | VIROG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVIROGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.8x | −1.6x | −0.6x | |
PEG Ratio | −0.07 | −0.02 | 0.00 | |
Price/Book | 3.9x | 3.5x | 2.6x | |
Price / LTM Sales | 5.3x | 2.9x | 3.3x | |
Upside (Analyst Target) | - | 106.6% | 44.5% | |
Fair Value Upside | Unlock | 15.5% | 6.0% | Unlock |
FAQ
What Is the ViroGates (VIROG) Stock Price Today?
The ViroGates stock price today is 5.75.
What Stock Exchange Does ViroGates Trade On?
ViroGates is listed and trades on the Copenhagen stock exchange.
What Is the Stock Symbol for ViroGates?
The stock symbol for ViroGates is "VIROG."
What Is the ViroGates Market Cap?
As of today, ViroGates market cap is 37.06M.
What is ViroGates Earnings Per Share?
The ViroGates EPS is -2.04.
What Is the Next ViroGates Earnings Date?
ViroGates will release its next earnings report on 06 Nov 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.